NeoCart Phase 2 Clinical Trial

Completed · Phase 2

Conditions studied: Articular Cartilage Damage

In brief

The objective of this study is to gather additional information regarding the performance of NeoCart to fill articular cartilage defects in the knee.

Key facts

Study ID

NCT00548119

Run by

Histogenics Corporation

People needed

30

Starts

2006-12-01

Expected to finish

2014-03-01

Last updated by the study team

2014-04-21

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients presenting with symptomatic knee pain indicative of an articular cartilage injury and able and willing to give informed consent.

You may not qualify if…

• Patients with any previous surgical treatment other than debridement or microfracture of the study cartilage defect.

Where it is running

• UCSF — San Francisco, California, United States
• TRIA Orthopedic Center — Bloomington, Minnesota, United States
• Hospital for Special Surgery — New York, New York, United States
• Keller Army Community Hospital — West Point, New York, United States
• Duke Sports Medicine Center — Durham, North Carolina, United States
• OHSU — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.